A recent study by CUHK Medicine found that 40% of Hong Kong people shown gut dysbiosis comparable to that of COVID-19 patients. Such dysbiosis is related to impaired immunity. With big data analysis and metagenomics derived from COVID-19 patients, researchers developed a unique microbiome immunity formula that enhances antibody formation and restore dysbiosis in COVID-19
